Alliancebernstein L.P. 9 Meters Biopharma, Inc. Transaction History

Alliancebernstein L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.26 - $0.64 $9,802 - $24,128	-37,700 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$0.52 - $1.0 $156 - $300	300 Added 0.8%	37,700 $23,000
Q2 2021 Jul 30, 2021	BUY	$1.04 - $1.5 $38,896 - $56,100	37,400 New	37,400 $41,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.